No Data
NeuroStar Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents With Depression
Neuronetics Will Acquire Greenbrook Through All-Stock Transaction; Interim Order Granted By Ontario Superior Court, Greenbrook Shareholders To Receive 0.01149 Neuronetics Shares Per Greenbrook Share, Ensuring 57% Ownership Of Combined Entity For...
Press Release: Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Meetings
Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents
Neuronetics Announces That Additional Payors Have Updated Their TMS Coverage To Reduce Access Barriers For Patients With Major Depressive Disorder
Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults